Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental Growth Factor vs PRP in Peripheral Nerve Injury
NCT06638008Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Randomised, open-label trial of platelet-rich plasma in peripheral nerve injury (PNI) (3 arms), sponsored by Assiut University. Primary endpoints: Efficacy of placental growth factor injection guided by ultrasound and nerve conduction at 1 year and Efficacy of platelet rich plasma injection guided by ultrasound and nerve conduction at 1 year. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT06638008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06638008.